PLD vs TPST · P/E 27, rev $8.79B vs $26.3M cap
Prologis Inc (PLD) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
TPST does not have a complete income-statement cache yet.
PLD currently screens at market cap $100.23B and trailing P/E 26.9. TPST currently screens at market cap $26.3M.
Not investment advice. Open the PLD and TPST stock pages for the full models.
Not investment advice.